Literature DB >> 12382306

Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests.

Arthur F Kavanaugh1, Daniel H Solomon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12382306     DOI: 10.1002/art.10558

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  49 in total

1.  [Systemic lupus erythematosus].

Authors:  C Kneitz; M Goebeler; H P Tony
Journal:  Internist (Berl)       Date:  2003-12       Impact factor: 0.743

2.  Myth and reality: practical test system for the measurement of anti-DNA antibodies in the diagnosis of systemic lupus erythematosus (SLE).

Authors:  Laura J McCloskey; Paul Christner; Dana Jacobs-Kosmin; Troy D Jaskowski; Harry R Hill; Gabriella Lakos; Marius Teodorescu
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

3.  Prior anti-dsDNA antibody status does not predict later disease manifestations in systemic lupus erythematosus.

Authors:  Loes van den Berg; Hans Nossent; Ole Rekvig
Journal:  Clin Rheumatol       Date:  2005-11-23       Impact factor: 2.980

4.  A proposed model for effective collaboration between rheumatologists and clinical pathologists for the diagnosis of autoimmune rheumatic diseases.

Authors:  Nicola Bizzaro; Gabriella Morozzi
Journal:  Rheumatol Int       Date:  2008-11-22       Impact factor: 2.631

5.  Autoantibodies to box A of high mobility group box 1 in systemic lupus erythematosus.

Authors:  F Schaper; K de Leeuw; G Horst; F Maas; H Bootsma; P Heeringa; P C Limburg; J Westra
Journal:  Clin Exp Immunol       Date:  2017-03-27       Impact factor: 4.330

Review 6.  Standardization of anti-DNA antibody assays.

Authors:  David S Pisetsky
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

Review 7.  Advances in the care of children with lupus nephritis.

Authors:  Scott E Wenderfer; Natasha M Ruth; Hermine I Brunner
Journal:  Pediatr Res       Date:  2016-11-17       Impact factor: 3.756

8.  High titer anti-basement membrane antibodies in a subset of patients with pediatric systemic lupus erythematosus.

Authors:  Alvaro Orjuela; Adisak Suwanichkul; Debra Canter; Charles G Minard; Sridevi Devaraj; M John Hicks; Eyal Muscal; Scott E Wenderfer
Journal:  Am J Nephrol       Date:  2015-04-25       Impact factor: 3.754

9.  Correlation between Systemic Lupus Erythematosus Disease Activity Index, C3, C4 and Anti-dsDNA Antibodies.

Authors:  K Narayanan; V Marwaha; K Shanmuganandan; S Shankar
Journal:  Med J Armed Forces India       Date:  2011-07-21

10.  Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus.

Authors:  Olivier C Meyer; Pascale Nicaise-Roland; Nolwenn Cadoudal; Sabine Grootenboer-Mignot; Elisabeth Palazzo; Gilles Hayem; Philippe Dieudé; Sylvie Chollet-Martin
Journal:  Arthritis Res Ther       Date:  2009-06-10       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.